HIV Patient ART Monitoring Meeting: International Conference Centre, Geneva 29-31 March 2004 Defining the variables.

Slides:



Advertisements
Similar presentations
Overview/Importance of HMIS
Advertisements

New Challenges in M&E Lets go. Scaling Up Monitoring & Evaluation Strategic Information PROGRAM GUIDANCE RESULT NEEDS OPPORTUNITIES Resources New directions.
Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July Ties Boerma HIV Department Surveillance,
Group III: Demand Forecasting
TB/HIV Research Priorities: TB Preventive Therapy.
Follow-up after training and supportive supervision The IMAI District Coordinator Course.
John Aberle-Grasse CDC GAP Strategies for Building National-Scale Longitudinal Patient Monitoring Systems for HIV Treatment and Care Lusaka, October 2-5,
Bobby Jefferson Senior HMIS Advisor Futures Group The Site Capacity Assessment (SCA) Tool and other Mechanisms to Monitor Transition Status Track 1 Implementers.
PARIS 21 Meeting Ghana July Challenges in health information Health Metrics Network HMN Framework and profiling tool.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Software Based Systems for ART Program and Patient Monitoring.
1 Interpretation and use. 2 The walls inside are plastered with laboriously made graphs…
Importance of Health Information Systems Information explosion during 1990s  It is estimated that in the next 50 years, the amount of knowledge currently.
One SADC, One Vision, One Way Working Together Towards MDG 6: SADC’s Common Vision Hon. Benedict Xaba, Minister of Health of Swaziland International AIDS.
Zimbabwe National HIV&AIDS Conference, Harare, 5-8 Sept 2011
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
Jennifer Hillebrand, „Rehabilitation of Drug Addicted Persons: Experience of Lithuania and European Countries”, 18 October 2007 Improving drug treatment.
 To what extent is IMCI implemented in NWP and what are the obstacles to its implementation?  What is the impact of IMCI in NWP?  What is the impact.
Confidentiality and Security Issues in ART & MTCT Clinical Monitoring Systems Meade Morgan and Xen Santas Informatics Team Surveillance and Infrastructure.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
Core Outcome Domains for Eczema – Results of a Delphi Consensus Project Introduction Eczema is a chronic, relapsing, inflammatory skin disorder that affects.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Uganda Health Information Strategy Eddie Mukooyo, MD, MSc Assistant Commissioner Health Services Dublin, Ireland 13 th September 2010.
Orientation on HIV care and ART Recording and Reporting System.
Challenges in monitoring ARV therapy A clinical and public health view of the issues involved Charlie Gilks SRM team, HIV department.
Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July
HELLEN A. WERE HEALTH ECONOMICS TRACK 2 ND COHORT UNITID FELLOWSHIP PROGRAM 24/05/2011.
Health Promotion as a Quality issue
More than just reinventing the wheel … Evidence review: Linking SRH and HIV Alejandra Trossero Senior HIV Officer: Linking SRH and HIV.
From Mekong to Bali: The scale up of TB/HIV collaborative activities in Asia- Pacific, August 8-9, 2009 Denpasar, Bali, Indonesia "TB/HIV Monitoring and.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
21/4/2008 Evaluation of control measures 1. 21/4/2008 Evaluation of control measures 2 Family and Community Medicine Department.
Assuring Safety for Clinical Techniques and Procedures MODULE 5 Facilitative Supervision for Quality Improvement Curriculum 2008.
INDEPTH Network Effectiveness and Safety Studies Platform (INESS) Update-INDEPTH AGM 2010 Aziza Mwisongo INESS secretariat Sep, 2010.
HIV/AIDS Track Session. Key Points Application of international reference price list during a national tender is a valuable tool for achieving optimal.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.
Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
HHS/CDC Track 1.0 Transition in Rwanda Dr Ida Kankindi, Rwanda Ministry of Health Dr Felix Kayigamba, CDC-Rwanda August
Strengthening Integration between RMNCH and HIV services Nuhu Yaqub WHO Tanzania.
Early DETECTion and integrated management of TuBerculosis in europe: E-DETECT TB Professor Ibrahim Abubakar Director, Institute for Global Health University.
11 Laboratory Quality Improvement for clinical HIV/AIDS Services in the Uniformed Forces Mwaibako, J, Shija, L; Haverkamp, G; van den Hombergh; Katebalila,
Definition of indicators Facilitators’ Workshop on District Health Performance Improvement Lilongwe, 25 th – 27 th March 2015.
Integration of HRH in MNCH and HIV services Director of Human resources development.
National TB Infection Control Seminar S’celo S. Dlamini Director: Research, Information, Monitoring, Evaluation & Surveillance 12 th of August 2015 Integrating.
WHO Estonia country office Marge Reinap Head of WHO Country Office in Estonia.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Strategic Information on ART Scale up Kevin O'Reilly Department of HIV/AIDS WHO.
Improving health worldwide Implications for Monitoring of the HIV Care Cascade? Jim Todd MeSH Satellite Session IAS Durban, Monday 18 th.
PMTCT PROGRAMME MONITORING DR. S.K CHATURVEDI DR. KANUPRIYA CHATURVEDI.
New WHO Guidelines on Person centred monitoring
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
A Quality Improvement Approach to PMTCT programs in South Africa
National and Global Monitoring of HIV Exposed, Uninfected Children
11 ii. Develop a plan for aDSM
12. Role of national and international technical and funding partners in the implementation of aDSM Multi-partner training package on active TB drug safety.
Dr. Kathure, Weyenga and Langat
Multi-Sectoral Nutrition Action Planning Training Module
Thokozani Kalua MBBS MSc Malawi Ministry of Health
Charles Gilks HIV Department, WHO
Paul De Lay Director, Evaluation UNAIDS
HIV Patient ART Monitoring Meeting: International Conference Centre, Geneva March 2004 Summary.
5th DEWG meeting Conclusions
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
11 iii. Define management and supervision roles and responsibilities
Stakeholder engagement and research utilization: Insights from Namibia
Training module on anthropometric data quality
Presentation transcript:

HIV Patient ART Monitoring Meeting: International Conference Centre, Geneva March 2004 Defining the variables

Aims of the meeting To discuss and identify those core variables to be collected for optimum patient management for ART monitoring in various settings (including PMTCT and Care for Women and Children programs) some of these would also allow for the evaluation and feedback of programs at various levels of the country’s health care system and harmonization of demands across relevant research or donor organizations operative in resource poor settings

Objectives of the meeting (1) 1. to discuss and agree on minimum variables to be collected at patient level for a) patient management; b) programme evaluation at facility, regional (provincial), national, and global levels

Objectives of the meeting (2) 2. to discuss and agree on patient based variables which will be useful in providing a link with the monitoring and evaluation of other programs: a) ART resistance b) drug supplies c) TB, other chronic care

Objectives of the meeting (3) to discuss and provide recommendations on mechanisms for collecting data at patient level

Objectives of the meeting (4) to discuss and provided recommendations on mechanisms of reporting and providing feedback at the level of health centre district Provincial national international

Objectives of the meeting (5) to discuss and provided recommendations on mechanisms systems to be used or developed including paper or electronic systems.

How do we think we can achieve these objectives? The meeting has brought together a number of experts in the field We would like you to split up into 3 work groups Group 1: patient group Group 2: program group Group 3: drug supply group

Patient Group Outcome: consensus on the minimum data set for monitoring clinical care for patients on ART in health facilities Tasks: to identify and discuss variables for patient management: ideal, minimum and realistic to identify low level indicators which can also be used for monitoring drug resistance to discuss how these data could be collected within each clinical unit, including who and how these data will be collected to discuss and agree on the next steps for implementation at local, country and global levels.

Program Group (1) Outcome: consensus on the minimum data set and system required for ART Program Monitoring at various levels (facility, district, national, and global) Tasks: identify the variables to monitor the programs, and their relationships with variables collected at health facility level to discuss how and how often these data should be transferred to higher level facilities including a critical review of the applicability of new technologies (e.g. software, smart cards, cell phones) in addition to paper based systems.

Program Group (2) how and how often these data will be analysed, by whom at which level and including a critical review of the applicability of various methods and means how and how often result of these analyses will be fed back to relevant levels to formulate recommendations on integration with the national HMIS with emphasis on records management including security and confidentiality, use and applications for M&E and surveillance. to agree on the next steps for implementation at local, country and global levels.

Drug Supply Group (1) Outcome: consensus on the minimum data set and system required for ART Drug Supply Monitoring at various levels (facility, district, national, and global) Tasks: identify the variables to monitor the drug supply programs, and their relationships with variables collected at health facility level to discuss how and how often these data on drug supplies will be transferred to higher level facilities including a critical review of the applicability of new technologies (e.g. software, smart cards, cell phones) in addition to paper based systems.

Drug Supply Group (2) To discuss how and how often these data on drug supplies will be analysed, by whom at which level and including a critical review of the applicability of various methods and means to discuss how and how often result of these analyses will be fed back to relevant levels to formulate recommendations on integration with the national HMIS with emphasis on records management including security and confidentiality, use and applications for M&E and surveillance. to agree on the next steps for implementation at local, country and global levels.

Variables ART Patient Monitoring demographic, including unique identifiers clinical, laboratory, treatment regimens HIV-related non-HIV, the extent of which may vary use of services inpatient services, especially inpatient days outpatient services, especially outpatient visits functional indicators

….so we can evaluate and improve where possible the Effectiveness Efficiency Equity Acceptability of the ART programs put into place

…but this is the only way …we are going to be to assess on an ongoing basis how successful the initiatives have been which have been instituted to contain the HIV pandemic and which additional interventions or systems are required

Practical points: Lists have been drawn up of who will go into which of the three groups While we are not going to compel you to comply with this, we would like the groups to be of similar sizes A member of each groups has been asked to act as rapporteur In addition, can each group please appoint its own facilitator and person(s) who will take extensive notes.

Thank you again ….for attending and taking part in this important exercise………

That's All Folks!